Nexiguran Ziclumeran Gene Editing in Hereditary ATTR with Polyneuropathy

J Julian D. Gillmore (University College London, National Amyloidosis Centre, Royal Free Hospital, London) E Ed Gane (University of Auckland, Auckland, New Zealand) J Jörg Täubel (Richmond Pharmacology, London) B Björn Pilebro (Umeå University, Umeå, Sweden) A Andoni Echaniz-Laguna (Bicêtre University Hospital, Assistance Publique–Hôpitaux de Paris, Université Paris-Saclay, Le Kremlin-Bicêtre, France) J Justin Kao (Auckland City Hospital, Auckland, New Zealand) W William Litchy (Mayo Clinic, Rochester, MN) S Safi Shahda (Intellia Therapeutics, Cambridge, MA) A Alexandra Haagensen (Intellia Therapeutics, Cambridge, MA) L Liron Walsh (Intellia Therapeutics, Cambridge, MA) D Derek Smith (Intellia Therapeutics, Cambridge, MA) J Jessica Kachadourian (Intellia Therapeutics, Cambridge, MA) J Jonathan H. Ward (Intellia Therapeutics, Cambridge, MA) D David Lebwohl (Intellia Therapeutics, Cambridge, MA) P Peijuan Zhu (Intellia Therapeutics, Cambridge, MA) Y Yuanxin Xu (Intellia Therapeutics, Cambridge, MA) A Adia Leung (Intellia Therapeutics, Cambridge, MA) A Alison Sonderfan (Intellia Therapeutics, Cambridge, MA) D David E. Gutstein (Regeneron Pharmaceuticals, Tarrytown, NY) G Garen Manvelian (Regeneron Pharmaceuticals, Tarrytown, NY) D David Adams (Bicêtre University Hospital, Assistance Publique–Hôpitaux de Paris, Université Paris-Saclay, Le Kremlin-Bicêtre, France)

Article Details

Volume / Issue Vol. 393, Issue 14
Published October 09, 2025
Pages 1375-1386
ISSN 0028-4793
Publisher Massachusetts Medical Society

Journal Info

New England Journal of Medicine

Massachusetts Medical Society

ISSN: 0028-4793 Social Sciences

Authors (21)

J

Julian D. Gillmore

University College London, National Amyloidosis Centre, Royal Free Hospital, London

E

Ed Gane

University of Auckland, Auckland, New Zealand

J

Jörg Täubel

Richmond Pharmacology, London

B

Björn Pilebro

Umeå University, Umeå, Sweden

A

Andoni Echaniz-Laguna

Bicêtre University Hospital, Assistance Publique–Hôpitaux de Paris, Université Paris-Saclay, Le Kremlin-Bicêtre, France

J

Justin Kao

Auckland City Hospital, Auckland, New Zealand

W

William Litchy

Mayo Clinic, Rochester, MN

S

Safi Shahda

Intellia Therapeutics, Cambridge, MA

A

Alexandra Haagensen

Intellia Therapeutics, Cambridge, MA

L

Liron Walsh

Intellia Therapeutics, Cambridge, MA

D

Derek Smith

Intellia Therapeutics, Cambridge, MA

J

Jessica Kachadourian

Intellia Therapeutics, Cambridge, MA

J

Jonathan H. Ward

Intellia Therapeutics, Cambridge, MA

D

David Lebwohl

Intellia Therapeutics, Cambridge, MA

P

Peijuan Zhu

Intellia Therapeutics, Cambridge, MA

Y

Yuanxin Xu

Intellia Therapeutics, Cambridge, MA

A

Adia Leung

Intellia Therapeutics, Cambridge, MA

A

Alison Sonderfan

Intellia Therapeutics, Cambridge, MA

D

David E. Gutstein

Regeneron Pharmaceuticals, Tarrytown, NY

G

Garen Manvelian

Regeneron Pharmaceuticals, Tarrytown, NY

D

David Adams

Bicêtre University Hospital, Assistance Publique–Hôpitaux de Paris, Université Paris-Saclay, Le Kremlin-Bicêtre, France